The DOJ Moves to Freeze the Abortion Pill Ban A ruling from Texas that would ban mifepristone nationwide is already taking on legal challenges. Story:
The American Medical Association condemned the decision as flying in the face of proven science and medical research. “This decision introduces the extraordinary, unprecedented danger of courts upending longstanding drug regulatory decisions by the U.S. Food and Drug Administration,” the group wrote.
The DOJ’s request is not the only legal challenge to Kacsmaryk’s decision. In a separate ruling issued hours after the decision, Washington District Court Judge Thomas O. Rice ordered the FDA to maintain the “status quo” availability of the medication. The ruling prevents the FDA from acting on Kacsmaryk’s order to pull the medication from public availability until the Supreme Court settles the dispute between the conflicting rulings.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
DOJ asks appeals court for emergency stay of abortion pill rulingThe Justice Department told the 5th Circuit Court of Appeals a district judge's 'extraordinary and unprecedented order' should be stayed pending an appeal.
Read more »
DOJ urges federal appeals court to block Texas abortion pill rulingNEW: The Justice Department formally appealed the Texas judge's decision that seeks to block the FDA's approval of a commonly used abortion pill.
Read more »
DOJ asks appeals court to stay Texas ruling against FDA abortion drug approvalThe Justice Department asked the U.S. Court of Appeals for the 5th Circuit to stay a Texas judge's order to suspend the Food and Drug Administration's approval of a common abortion drug, asking for intervention no later than Thursday at noon.
Read more »
DOJ asks appeals court for emergency stay of abortion pill rulingJUST IN: The DOJ has filed an emergency stay motion with the 5th Circuit Court of Appeals seeking to block the order from a federal judge in Texas striking down the FDA's approval of the abortion medication drug mifepristone.
Read more »
Competing abortion pill rulings sow broad alarm, confusionCompeting rulings by two federal judges over the availability of the abortion pill mifepristone are sowing alarm and confusion — and opening a new front in the battle over abortion in the United States. One federal judge in Amarillo, Texas on Friday put on hold federal approval of mifepristone, one of the most commonly used medications to prevent pregnancies. Another federal judge in Spokane, Washington ruled differently in a separate case and ordered the federal government not to restrict the drug's availability. Some abortion rights advocates have little confidence the U.S. Supreme Court will side with abortion advocates on the abortion pill issue after the court last June struck down Roe v. Wade.
Read more »
Access to reproductive health care has become more challenging for women in the US, study shows | CNNAs abortion rights become more restricted in the United States, a new study shows that it's become harder for women to access reproductive health care services -- such as routine screenings and birth control -- in recent years. ((Did this study focus on non-abortion reproductive health care/exclude abortion, or is abortion ALSO a part of this data? I'm wondering if we should emphasize more specifics in the headline so people don't read this as meaning abortion, when it's really broader or exclusive of that. // survey let people interpret themselves, but they were prompted: 'Reproductive health services were described to participants as 'a Pap smear, which is a test to check for cervical cancer, or family planning, like birth control methods.' how does this this tweak work? took out 'other' and went with 'more broadly' ))
Read more »